Observational usage and efficacy study of candesartan in heart failure treatment in France - SISTOLA
Study identifier:NIS-CFR-ATA-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Observational usage and efficacy study of candesartan in heart failure treatment in France
Medical condition
heart failure
Phase
-
Healthy volunteers
No
Study drug
Candesartan
Sex
All
Actual Enrollment
450
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jan 2008
Primary Completion Date: 01 Jun 2010
Study Completion Date: 01 Jul 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Takeda
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure | Drug: Candesartan Oral tablets Other Name: Atacand |
Contacts
Investigators
Principal Investigator
Stephane Bouee
CEMKA EVAL - Bourg La Reine - France
